RA Capital Management’s Travere Therapeutics TVTX Stock Holding History

RA Capital Management’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-746,841	Closed	-$22.2M	–	95
2026 Q1	$22.2M	Buy	+746,841	New	+$22.3M	0.24%	55
2025 Q4	–	Sell	-1,150,000	Closed	-$27.5M	–	87
2025 Q3	$27.5M	Hold	1,150,000	–	–	0.34%	38
2025 Q2	$17M	Hold	1,150,000	–	–	0.29%	39
2025 Q1	$20.6M	Hold	1,150,000	–	–	0.34%	41
2024 Q4	$20M	Buy	+1,150,000	New	+$20.3M	0.27%	56
2023 Q1	–	Sell	-3,984,681	Closed	-$83.8M	–	69
2022 Q4	$83.8M	Sell	3,984,681 -938,260	-19%	-$19.9M	1.7%	22
2022 Q3	$121M	Hold	4,922,941	–	–	2.59%	8
2022 Q2	$119M	Hold	4,922,941	–	–	3.18%	6
2022 Q1	$127M	Sell	4,922,941 -691,487	-12%	-$18.4M	2.77%	6
2021 Q4	$174M	Hold	5,614,428	–	–	3.07%	4
2021 Q3	$136M	Hold	5,614,428	–	–	1.89%	17
2021 Q2	$81.9M	Hold	5,614,428	–	–	1.31%	24
2021 Q1	$140M	Buy	5,614,428 +1,056,561	+23%	+$29.2M	2.11%	12
2020 Q4	$124M	Sell	4,557,867 -77,820	-2%	-$1.82M	1.74%	15
2020 Q3	$85.6M	Hold	4,635,687	–	–	1.57%	21
2020 Q2	$94.6M	Buy	4,635,687 +469,234	+11%	+$7.47M	1.84%	21
2020 Q1	$60.8M	Sell	4,166,453 -86,000	-2%	-$1.29M	1.92%	20
2019 Q4	$60.4M	Buy	4,252,453 +264,893	+7%	+$3.38M	1.83%	16
2019 Q3	$46.2M	Buy	+3,987,560	New	+$65.9M	2.75%	11

Other funds holding TVTX

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RA Capital Management's TVTX Position: Q2 2026 in Review

RA Capital Management sold out of Travere Therapeutics (TVTX) in Q2 2026, closing a stake of 746,841 shares — an estimated $22.2M sold.

RA Capital Management first reported a position in TVTX in Q3 2019 and held it in 19 quarters. The position peaked at $174M in Q4 2021. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

RA Capital Management reported no remaining Travere Therapeutics position as of Q2 2026 after selling out during the quarter.
RA Capital Management sold 746,841 Travere Therapeutics shares in Q2 2026, an estimated $22.2M.
RA Capital Management first reported a position in Travere Therapeutics in Q3 2019 and held it in 19 quarters.
RA Capital Management's Travere Therapeutics position peaked at $174M in Q4 2021.
321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on RA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.